Level/ Type |
Code |
Display Name |
Code System |
0‑L |
8000/0
|
Tumeur bénigne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8000/1
|
Tumeur de bénignité ou de malignité non assurée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8000/3
|
Tumeur maligne, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8000/6
|
Tumeur métastatique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8000/9
|
Tumeur maligne de nature primaire ou secondaire non assurée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8001/0
|
Cellules tumorales bénignes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8001/1
|
Cellules tumorales de bénignité ou de malignité non assurée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8001/3
|
Cellules tumorales malignes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8002/3
|
Tumeur maligne à petites cellules
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8003/3
|
Tumeur maligne à grandes cellules
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8004/3
|
Tumeur maligne à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8005/0
|
Tumeur à cellules claires, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8005/3
|
Tumeur maligne à cellules claires
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8010/0
|
Tumeur épithéliale bénigne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8010/2
|
Carcinome in situ, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8010/3
|
Carcinome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8010/6
|
Carcinome métastatique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8010/9
|
Carcinomatose
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8011/0
|
Épithéliome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8011/3
|
Épithéliome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8012/3
|
Carcinome à grandes cellules, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8013/3
|
Carcinome neuroendocrinien à grandes cellules
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8014/3
|
Carcinome à grandes cellules avec un phénotype rhabdoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8015/3
|
Carcinome à cellules hyalines
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8020/3
|
Carcinome indifférencié, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8021/3
|
Carcinome anaplasique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8022/3
|
Carcinome pléomorphe
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8030/3
|
Carcinome à cellules géantes et à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8031/3
|
Carcinome à cellules géantes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8032/3
|
Carcinome à cellules fusiformes, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8033/3
|
Carcinome pseudosarcomateux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8034/3
|
Carcinome à cellules polygonales
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8035/3
|
Carcinome à cellules géantes ostéoclastiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8040/0
|
Tumorlet bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8040/1
|
Tumorlet, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8041/3
|
Carcinome à petites cellules, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8042/3
|
Carcinome à cellules en grain d’avoine (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8043/3
|
Carcinome à petites cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8044/3
|
Carcinome à petites cellules intermédiaires
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8045/3
|
Carcinome mixte à petites cellules
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8046/3
|
Carcinome non à petites cellules (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8050/0
|
Papillome, SAI (à l’exclusion du papillome de la vessie M-8120/1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8050/2
|
Carcinome papillaire in situ
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8050/3
|
Carcinome papillaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8051/0
|
Papillome verruqueux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8051/3
|
Carcinome verruqueux, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8052/0
|
Papillome spinocellulaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8052/2
|
Carcinome épidermoïde papillaire non invasif
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8052/3
|
Carcinome épidermoïde papillaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8053/0
|
Papillome épidermoïde inversé
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8060/0
|
Papillomatose épidermoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8070/2
|
Carcinome épidermoïde in situ, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8070/3
|
Carcinome épidermoïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8070/6
|
Carcinome épidermoïde, métastatique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8071/3
|
Carcinome épidermoïde kératinisant, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8072/3
|
Carcinome épidermoïde non kératinisant, à grandes cellules, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8073/3
|
Carcinome épidermoïde non kératinisant, à petites cellules
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8074/3
|
Carcinome épidermoïde à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8075/3
|
Carcinome épidermoïde pseudo-glandulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8076/2
|
Carcinome épidermoïde in situ avec possibilité d’envahissement du stroma
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8076/3
|
Carcinome épidermoïde micro-invasif
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8077/2
|
Néoplasie intraépithéliale, grade III
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8078/3
|
Carcinome épidermoïde avec formation d’une corne cutanée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8080/2
|
Érythroplasie de Queyrat (C60.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8081/2
|
Maladie de Bowen (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8082/3
|
Carcinome lymphoépithélial
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8083/3
|
Carcinome épidermoïde basaloïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8084/3
|
Carcinome épidermoïde à cellules claires
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8090/1
|
Tumeur basocellulaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8090/3
|
Carcinome basocellulaire, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8091/3
|
Carcinome basocellulaire superficiel multifocal (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8092/3
|
Carcinome basocellulaire infiltrant, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8093/3
|
Carcinome basocellulaire fibro-épithélial (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8094/3
|
Carcinome basospinocellulaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8095/3
|
Carcinome intermédiaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8096/0
|
Épithéliome intra-épidermique de Borst et Jadassohn (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8097/3
|
Carcinome basocellulaire nodulaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8098/3
|
Carcinome basocellulaire adénoïde (C53.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8100/0
|
Trichoépithéliome (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8101/0
|
Trichofolliculome (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8102/0
|
Trichilemmome (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8102/3
|
Trichilemmocarcinome (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8103/0
|
Tumeur pilaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8110/0
|
Pilomatrixome, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8110/3
|
Carcinome pilomatriciel (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8120/0
|
Papillome bénin à cellules transitionnelles
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8120/1
|
Papillome à cellules transitionnelles, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8120/2
|
Carcinome à cellules transitionnelles in situ
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8120/3
|
Carcinome à cellules transitionnelles, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8121/0
|
Papillome schneidérien, SAI (C30.0, C31.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8121/1
|
Papillome transitionnel inversé, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8121/3
|
Carcinome schneidérien (C30.0, C31.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8122/3
|
Carcinome transitionnel à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8123/3
|
Carcinome basaloïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8124/3
|
Tumeur cloacale maligne (C21.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8130/1
|
Tumeur transitionnelle papillaire à faible potentiel malin (C67.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8130/2
|
Carcinome transitionnel papillaire non invasif (C67.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8130/3
|
Carcinome transitionnel papillaire (C67.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8131/3
|
Carcinome transitionnel micro-papillaire (C67.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8140/0
|
Adénome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8140/1
|
Adénome atypique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8140/2
|
Adénocarcinome in situ, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8140/3
|
Adénocarcinome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8140/6
|
Adénocarcinome métastatique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8141/3
|
Adénocarcinome squirrheux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8142/3
|
Linite plastique (C16.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8143/3
|
Adénocarcinome à extension superficielle
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8144/3
|
Adénocarcinome de type intestinal (C16.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8145/3
|
Carcinome de type diffus (C16.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8146/0
|
Adénome monomorphe
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8147/0
|
Adénome basocellulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8147/3
|
Adénocarcinome basocellulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8148/2
|
Néoplasie glandulaire intraépithéliale, grade III
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8149/0
|
Adénome canaliculaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8150/0
|
Adénome insulaire, SAI (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8150/1
|
Tumeur à cellules insulaires, SAI (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8150/3
|
Carcinome insulaire du pancréas (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8151/0
|
Insulinome, SAI (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8151/3
|
Insulinome malin (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8152/1
|
Glucagonome, SAI (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8152/3
|
Glucagonome malin (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8153/1
|
Gastrinome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8153/3
|
Gastrinome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8154/3
|
Adénocarcinome à cellules insulaires et à cellules exocrines (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8155/3
|
Vipome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8156/1
|
Somatostatinome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8156/3
|
Somatostatinome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8157/1
|
Entéroglucagonome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8157/3
|
Entéroglucagonome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8160/0
|
Cholangiome bénin (C22.1, C24.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8160/3
|
Cholangiocarcinome (C22.1, C24.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8161/0
|
Cystadénome biliaire (C22.1, C24.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8161/3
|
Cystadénocarcinome biliaire (C22.1, C24.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8162/3
|
Tumeur de Klatskin (C22.1, C24.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8170/0
|
Hépatome bénin (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8170/3
|
Carcinome hépatocellulaire, SAI (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8171/3
|
Carcinome hépatocellulaire fibrolamellaire (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8172/3
|
Carcinome hépatocellulaire squirrheux (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8155/1
|
Vipome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8173/3
|
Carcinome hépatocellulaire, variante à cellules fusiformes (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8174/3
|
Carcinome hépatocellulaire à cellules claires (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8175/3
|
Carcinome hépatocellulaire pléomorphe (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8180/3
|
Carcinome hépatocellulaire et cholangiocarcinome combinés (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8190/0
|
Adénome trabéculaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8190/3
|
Adénocarcinome trabéculaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8191/0
|
Adénome embryonnaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8200/0
|
Cylindrome eccrine dermique (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8200/3
|
Carcinome adénoïde kystique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8201/2
|
Carcinome cribriforme intra-épithélial (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8201/3
|
Carcinome cribriforme, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8202/0
|
Adénome microkystique (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8204/0
|
Adénome de lactation (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8210/0
|
Polype adénomateux, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8210/2
|
Adénocarcinome in situ sur polype adénomateux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8210/3
|
Adénocarcinome sur polyadénome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8211/0
|
Adénome tubuleux, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8211/3
|
Adénocarcinome tubuleux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8212/0
|
Adénome plat
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8213/0
|
Adénome dentelé (C18.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8214/3
|
Carcinome à cellules pariétales (C16.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8215/3
|
Adénocarcinome des glandes anales (C21.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8220/0
|
Adénomatose polypoïde du côlon (C18.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8220/3
|
Adénocarcinome sur adénomatose polypoïde du côlon (C18.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8221/0
|
Polypose multiple
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8221/3
|
Adénocarcinome sur polypes adénomateux multiples
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8230/2
|
Carcinome canalaire intraépithélial solide (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8230/3
|
Carcinome solide, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8231/3
|
Carcinome simplex
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8240/1
|
Tumeur carcinoïde de potentiel malin incertain
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8240/3
|
Tumeur carcinoïde , SAI (sauf appendice, M-8240/1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8241/3
|
Carcinoïde malin à cellules entérochromaffines
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8242/1
|
Carcinoïde à cellules entérochromaffinoïdes, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8242/3
|
Carcinoïde malin à cellules entérochromaffinoïdes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8243/3
|
Tumeur maligne mucocarcinoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8244/3
|
Tumeur carcinoïde mixte
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8245/1
|
Carcinoïde tubuleux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8245/3
|
Tumeur adénocarcinoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8246/3
|
Carcinome neuroendocrinien, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8247/3
|
Carcinome à cellules de Merkel (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8248/1
|
Apudome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8249/3
|
Tumeur carcinoïde maligne atypique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8250/1
|
Adénomatose pulmonaire (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8250/3
|
Adénocarcinome bronchioloalvéolaire, SAI (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8251/0
|
Adénome alvéolaire (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8251/3
|
Adénocarcinome alvéolaire (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8252/3
|
Carcinome bronchioloalvéolaire non mucineux (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8253/3
|
Carcinome bronchioloalvéolaire mucineux (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8254/3
|
Carcinome bronchioloalvéolaire mixte mucineux et non mucineux (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8255/3
|
Adénocarcinome avec sous-types mixtes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8260/0
|
Adénome papillaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8260/3
|
Adénocarcinome papillaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8261/0
|
Adénome villeux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8261/2
|
Adénocarcinome in situ sur adénome villeux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8261/3
|
Adénocarcinome sur adénome villeux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8262/3
|
Adénocarcinome villeux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8263/0
|
Adénome tubulovilleux, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8263/2
|
Adénocarcinome in situ sur adénome tubulovilleux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8263/3
|
Adénocarcinome sur adénome tubulovilleux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8264/0
|
Papillomatose glandulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8270/0
|
Adénome chromophobe (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8270/3
|
Adénocarcinome chromophobe (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8271/0
|
Prolactinome (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8272/0
|
Adénome pituitaire, SAI (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8272/3
|
Carcinome pituitaire, SAI (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8280/0
|
Adénome acidophile (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8280/3
|
Adénocarcinome éosinophile (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8281/0
|
Adénome mixte acidophile et basophile (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8281/3
|
Adénocarcinome mixte acidophile et basophile (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8290/0
|
Adénome oxyphile
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8290/3
|
Adénocarcinome oxyphile
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8300/0
|
Adénome basophile (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8300/3
|
Adénocarcinome à cellules basophiles (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8310/0
|
Adénome à cellules claires
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8310/3
|
Adénocarcinome à cellules claires, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8311/1
|
Tumeur hypernéphroïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8312/3
|
Carcinome à cellules rénales, SAI (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8313/0
|
Adénofibrome à cellules claires (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8313/1
|
Adénofibrome à cellules claires à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8313/3
|
Adénocarcinofibrome à cellules claires (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8314/3
|
Carcinome riche en lipides (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8315/3
|
Carcinome riche en glycogènes (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8316/3
|
Carcinome à cellules rénales associé à un kyste (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8317/3
|
Carcinome à cellules rénales chromophobes (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8318/3
|
Carcinome à cellules rénales sarcomatoïde (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8319/3
|
Carcinome des tubes droits du rein (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8320/3
|
Carcinome à cellules granuleuses
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8321/0
|
Adénome à cellules principales (C75.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8322/0
|
Adénome à cellules eau de roche (C75.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8322/3
|
Adénocarcinome à cellules eau de roche (C75.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8323/0
|
Adénome à cellules mixtes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8323/3
|
Adénocarcinome à cellules mixtes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8324/0
|
Adénolipome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8325/0
|
Adénome métanéphrique (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8330/0
|
Adénome vésiculaire (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8330/1
|
Adénome vésiculaire atypique (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8330/3
|
Adénocarcinome vésiculaire, SAI (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8331/3
|
Adénocarcinome vésiculaire bien différencié (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8332/3
|
Adénocarcinome vésiculaire trabéculaire (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8333/0
|
Adénome microvésiculaire, SAI (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8333/3
|
Adénocarcinome fœtal
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8334/0
|
Adénome macrovésiculaire (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8335/3
|
Carcinome vésiculaire microinvasif (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8336/0
|
Adénome trabéculaire hyalinisant (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8337/3
|
Carcinome insulaire (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8340/3
|
Carcinome papillaire, variante vésiculaire (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8341/3
|
Microcarcinome papillaire (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8342/3
|
Carcinome papillaire à cellule oxyphile (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8343/3
|
Carcinome papillaire encapsulé (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8344/3
|
Carcinome papillaire à cellules cylindriques (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8345/3
|
Carcinome médullaire à stroma amyloïde (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8346/3
|
Carcinome mixte médullaire et vésiculaire (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8347/3
|
Carcinome mixte médullaire et papillaire (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8350/3
|
Carcinome sclérosant non encapsulé (C73.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8360/1
|
Adénomatose endocrinienne multiple
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8361/0
|
Tumeur juxtaglomérulaire (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8370/0
|
Adénome corticosurrénalien, SAI (C74.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8370/3
|
Corticosurrénalome malin (C74.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8371/0
|
Adénome corticosurrénalien à cellules compactes (C74.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8372/0
|
Adénome corticosurrénalien pigmenté (C74.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8373/0
|
Adénome corticosurrénalien à cellules claires (C74.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8374/0
|
Adénome corticosurrénalien à cellules glomérulaires (C74.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8375/0
|
Adénome corticosurrénalien à cellules mixtes (C74.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8380/0
|
Adénome endométrioïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8380/1
|
Adénome endométrioïde à la limite de la malignité
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8380/3
|
Adénocarcinome endométrioïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8381/0
|
Adénofibrome endométrioïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8381/1
|
Adénofibrome endométrioïde à la limite de la malignité
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8381/3
|
Adénofibrome endométrioïde malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8382/3
|
Adénocarcinome endométrioïde, variante sécrétoire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8383/3
|
Adénocarcinome endométrioïde, variante à cellules ciliées
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8384/3
|
Adénocarcinome de type endocervical
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8390/0
|
Adénome des annexes cutanées (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8390/3
|
Carcinome des annexes cutanées (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8391/0
|
Fibrome folliculaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8392/0
|
Syringofibroadénome (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8400/0
|
Adénome des glandes sudoripares (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8400/1
|
Tumeur des glandes sudoripares, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8400/3
|
Adénocarcinome des glandes sudoripares (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8401/0
|
Adénome apocrine
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8401/3
|
Adénocarcinome apocrine
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8402/0
|
Hidradénome nodulaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8402/3
|
Hidradénome nodulaire malin (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8403/0
|
Spiradénome eccrine (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8403/3
|
Spiradénome eccrine malin (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8404/0
|
Hidrocystome (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8405/0
|
Hidradénome papillaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8406/0
|
Syringoadénome papillaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8407/0
|
Syringome, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8407/3
|
Carcinome sclérosant d’un canal sudorifère (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8408/0
|
Adénome papillaire eccrine (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8408/1
|
Adénome papillaire digital agressif (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8408/3
|
Adénocarcinome papillaire eccrine (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8409/0
|
Porome eccrine (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8409/3
|
Porome eccrine malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8410/0
|
Adénome sébacé (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8410/3
|
Adénocarcinome sébacé (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8413/3
|
Adénocarcinome eccrine (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8420/0
|
Adénome cérumineux (C44.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8420/3
|
Adénocarcinome cérumineux (C44.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8430/1
|
Tumeur muco-épidermoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8430/3
|
Carcinome muco-épidermoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8440/0
|
Cystadénome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8440/3
|
Cystadénocarcinome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8441/0
|
Cystadénome séreux, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8441/3
|
Cystadénocarcinome séreux, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8442/1
|
Cystadénome séreux à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8443/0
|
Cystadénome à cellules claires (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8444/1
|
Tumeur kystique à cellules claires à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8450/0
|
Cystadénome papillaire, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8450/3
|
Cystadénocarcinome papillaire, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8451/1
|
Cystadénome papillaire à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8452/1
|
Tumeur pseudopapillaire solide (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8470/0
|
Cystadénome mucineux, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8470/1
|
Tumeur kystique mucineuse avec dysplasie modérée (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8470/2
|
Cystadénocarcinome mucineux, non invasif (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8452/3
|
Carcinome pseudopapillaire solide (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8453/0
|
Adénome intracanalaire mucineux et papillaire (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8453/1
|
Tumeur intracanalaire mucineuse et papillaire avec dysplasie modérée (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8453/2
|
Carcinome intracanalaire mucineux et papillaire, non invasif (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8453/3
|
Carcinome intracanalaire mucineux et papillaire, invasif (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8454/0
|
Tumeur kystique du nœud auriculo-ventriculaire (C38.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8460/0
|
Cystadénome séreux papillaire, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8460/3
|
Cystadénocarcinome séreux papillaire (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8461/0
|
Papillome séreux de surface, (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8461/3
|
Carcinome séreux papillaire de surface (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8462/1
|
Tumeur kystique séreuse papillaire à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8463/1
|
Tumeur séreuse papillaire de surface à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8470/3
|
Cystadénocarcinome mucineux, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8471/0
|
Cystadénome papillaire mucineux, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8471/3
|
Cystadénocarcinome papillaire mucineux (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8472/1
|
Tumeur kystique mucineuse à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8473/1
|
Cystadénome papillaire mucineux à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8480/0
|
Adénome mucineux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8480/3
|
Adénocarcinome colloïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8480/6
|
Pseudomyxome du péritoine
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8481/3
|
Adénocarcinome mucipare
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8482/3
|
Adénocarcinome mucineux de type endocervical
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8490/3
|
Adénocarcinome à cellules en bague à chaton
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8490/6
|
Carcinome métastatique à cellules en bague à chaton
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8500/2
|
Carcinome intracanalaire non infiltrant, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8500/3
|
Adénocarcinome canalaire infiltrant, SAI (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8501/2
|
Comédocarcinome non infiltrant (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8501/3
|
Comédocarcinome, SAI (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8502/3
|
Carcinome juvénile du sein (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8503/0
|
Papillome intracanalaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8503/2
|
Adénocarcinome papillaire intracanalaire non infiltrant (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8503/3
|
Adénocarcinome papillaire intracanalaire infiltrant
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8504/0
|
Adénome papillaire intrakystique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8504/2
|
Carcinome intrakystique non infiltrant
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8504/3
|
Carcinome intrakystique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8505/0
|
Papillomatose intracanalaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8506/0
|
Adénomatose du mamelon (C50.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8507/2
|
Carcinome intracanalaire micropapillaire (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8508/3
|
Carcinome hypersécrétoire kystique (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8510/3
|
Carcinome médullaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8512/3
|
Carcinome médullaire à stroma lymphoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8513/3
|
Carcinome médullaire atypique (C50.- )
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8514/3
|
Carcinome canalaire de type desmoplasique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8520/2
|
Carcinome lobulaire in situ, SAI (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8520/3
|
Carcinome lobulaire, SAI (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8521/3
|
Carcinome canaliculaire infiltrant (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8522/2
|
Carcinome intracanalaire et carcinome lobulaire in situ (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8522/3
|
Carcinome canalaire et lobulaire infiltrant (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8523/3
|
Carcinome canalaire infiltrant avec autres types de carcinomes (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8524/3
|
Carcinome lobulaire infiltrant avec autres types de carcinomes (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8525/3
|
Adénocarcinome polymorphe de bas grade
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8530/3
|
Carcinome inflammatoire (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8540/3
|
Maladie de Paget du sein (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8541/3
|
Maladie de Paget et carcinome canalaire infiltrant du sein (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8542/3
|
Maladie de Paget extramammaire (à l’exclusion de la maladie de Paget de l’os)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8543/3
|
Maladie de Paget et carcinome intracanalaire du sein (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8550/0
|
Adénome à cellules acineuses Adénome acineux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8550/1
|
Tumeur à cellules acineuses
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8550/3
|
Adénocarcinome à cellules acineuses
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8551/3
|
Cystadénocarcinome à cellules acineuses
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8560/0
|
Papillome mixte glandulaire et spinocellulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8560/3
|
Carcinome adénosquameux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8561/0
|
Adénolymphome (C07.-, C08.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8562/3
|
Carcinome épithélial-myoépithélial
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8570/3
|
Adénocarcinome avec métaplasie malpighienne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8571/3
|
Adénocarcinome avec métaplasie cartilagineuse et osseuse
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8572/3
|
Adénocarcinome avec métaplasie fusocellulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8573/3
|
Adénocarcinome avec métaplasie apocrine
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8574/3
|
Adénocarcinome avec différenciation neuroendocrinienne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8575/3
|
Carcinome métaplasique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8576/3
|
Adénocarcinome hépatoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8580/0
|
Thymome bénin (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8580/1
|
Thymome, SAI (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8580/3
|
Thymome malin, SAI (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8581/1
|
Thymome de type A, SAI (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8581/3
|
Thymome malin de type A (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8582/1
|
Thymome de type AB, SAI (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8582/3
|
Thymome malin de type AB (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8583/1
|
Thymome de type B1, SAI (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8583/3
|
Thymome malin de type B1 (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8584/1
|
Thymome de type B2, SAI (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8584/3
|
Thymome malin de type B2 (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8585/1
|
Thymome de type B3, SAI (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8585/3
|
Thymome malin de type B3 (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8586/3
|
Carcinome thymique, SAI (C37.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8587/0
|
Thymome hamartomateux ectopique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8588/3
|
Tumeur épithéliale fusiforme avec éléments d’allure thymique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8589/3
|
Carcinome présentant des éléments d'allure thymique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8590/1
|
Tumeur des cordons sexuels et du stroma gonadique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8591/1
|
Tumeur des cordons sexuels et du stroma gonadique, partiellement différenciée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8592/1
|
Tumeur des cordons sexuels et du stroma gonadique, formes mixtes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8593/1
|
Tumeur du stroma gonadique avec peu d’éléments de cordons sexuels (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8600/0
|
Thécome, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8600/3
|
Thécome malin (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8601/0
|
Thécome lutéinisé (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8602/0
|
Tumeur stromale sclérosante (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8610/0
|
Lutéome, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8620/1
|
Tumeur de la granulosa de type adulte (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8620/3
|
Tumeur maligne de la granulosa (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8621/1
|
Tumeur de la granulosa et de la thèque (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8622/1
|
Tumeur de la granulosa juvénile (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8623/1
|
Tumeur des cordons sexuels avec tubules annulaires (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8630/0
|
Androblastome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8630/1
|
Androblastome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8630/3
|
Androblastome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8631/0
|
Tumeur à cellules de Sertoli-Leydig, bien différenciée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8631/1
|
Tumeur à cellules de Sertoli-Leydig de différenciation intermédiaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8631/3
|
Tumeur à cellules de Sertoli-Leydig, peu différenciée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8632/1
|
Gynandroblastome (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8633/1
|
Tumeur rétiforme à cellules de Sertoli-Leydig
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8634/1
|
Tumeur à cellules de Sertoli-Leydig, différenciation intermédiaire, avec éléments
hétérologues
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8634/3
|
Tumeur à cellules de Sertoli-Leydig, peu différenciée, avec éléments hétérologues
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8640/1
|
Tumeur à cellules de Sertoli, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8640/3
|
Carcinome à cellules de Sertoli (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8641/0
|
Tumeur à cellules de Sertoli lipidiques (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8642/1
|
Androblastome calcifiant à grandes cellules
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8650/0
|
Tumeur bénigne à cellules de Leydig (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8650/1
|
Tumeur à cellules de Leydig, SAI (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8650/3
|
Tumeur maligne à cellules de Leydig (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8660/0
|
Tumeur à cellules du hile (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8670/0
|
Tumeur à cellules lipoïdiques de l'ovaire (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8670/3
|
Tumeur maligne à cellules stéroïdiennes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8671/0
|
Tumeur des vestiges surrénaliens
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8680/0
|
Paragangliome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8680/1
|
Paragangliome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8680/3
|
Paragangliome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8681/1
|
Paragangliome sympathique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8682/1
|
Paragangliome parasympathique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8683/0
|
Paragangliome gangliocytaire (C17.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8690/1
|
Tumeur du glomus jugulaire, SAI (C75.5)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8691/1
|
Tumeur du corpuscule aortique (C75.5)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8692/1
|
Tumeur du corpuscule carotidien (C75.4)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8693/1
|
Paragangliome extrasurrénalien, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8693/3
|
Paragangliome extrasurrénalien malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8700/0
|
Phéochromocytome, SAI (C74.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8700/3
|
Phéochromocytome malin (C74.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8710/3
|
Glomangiosarcome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8711/0
|
Tumeur glomique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8711/3
|
Tumeur glomique maligne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8712/0
|
Glomangiome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8713/0
|
Glomangiomyome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8720/0
|
Nævus pigmentaire, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8720/2
|
Mélanome in situ
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8720/3
|
Mélanome malin, SAI (à l’exception du mélanome juvénile M-8770/0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8721/3
|
Mélanome nodulaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8722/0
|
Nævus à cellules ballonisées (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8722/3
|
Mélanome à cellules ballonisées (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8723/0
|
Nævus en halo (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8723/3
|
Mélanome malin régressant (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8725/0
|
Neuronævus (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8726/0
|
Nævus à grandes cellules (C69.4)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8727/0
|
Nævus dysplasique (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8728/0
|
Mélanocytose diffuse (C70.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8728/1
|
Mélanocytome méningé (C70.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8728/3
|
Mélanomatose méningée (C70.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8730/0
|
Nævus achromique (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8730/3
|
Mélanome achromique (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8740/0
|
Nævus de jonction, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8740/3
|
Mélanome malin sur enævus de jonction (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8741/2
|
Mélanose précancéreuse, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8741/3
|
Mélanome malin sur mélanose précancéreuse (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8742/2
|
Lentigo malin (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8742/3
|
Mélanome malin sur lentigo malin des vieillards (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8743/3
|
Mélanome à extension superficielle (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8761/3
|
Mélanome malin sur nævus pigmentaire géant (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8762/1
|
Lésion dermique proliférative sur nævus congénital (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8770/0
|
Nævus à cellules épithélioïdes et à cellules fusiformes (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8770/3
|
Mélanome à cellules épithélioïdes et à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8771/0
|
Nævus à cellules épithélioïdes (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8771/3
|
Mélanome à cellules épithélioïdes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8744/3
|
Mélanome acral lentigineux malin (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8772/0
|
Nævus à cellules fusiformes, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8745/3
|
Mélanome malin desmoplasique (C44.- )
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8746/3
|
Mélanome muqueux lentigineux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8750/0
|
Nævus intradermique (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8760/0
|
Nævus mixte (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8761/0
|
Petit nævus congénital (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8761/1
|
Nævus pigmentaire géant, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8772/3
|
Mélanome à cellules fusiformes, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8773/3
|
Mélanome à cellules fusiformes de type A (C69.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8774/3
|
Mélanome à cellules fusiformes de type B (C69.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8780/0
|
Nævus bleu, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8780/3
|
Nævus bleu malin (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8790/0
|
Nævus bleu cellulaire (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8800/0
|
Tumeur bénigne des tissus mous
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8800/3
|
Sarcome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8800/9
|
Sarcomatose, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8801/3
|
Sarcome à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8802/3
|
Sarcome à cellules géantes (à l’exception de l’os M-9250/3)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8803/3
|
Sarcome à petites cellules
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8804/3
|
Sarcome épithélioïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8805/3
|
Sarcome indifférencié
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8806/3
|
Tumeur desmoplastique à petites cellules rondes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8810/0
|
Fibrome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8810/1
|
Fibrome cellulaire (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8810/3
|
Fibrosarcome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8811/0
|
Fibromyxome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8811/3
|
Fibromyxosarcome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8812/0
|
Fibrome périostique (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8812/3
|
Fibrosarcome périostique (C40.-, C41.- )
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8813/0
|
Fibrome des fascias
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8813/3
|
Fibrosarcome des fascias
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8814/3
|
Fibrosarcome infantile
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8815/0
|
Tumeur fibreuse solitaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8815/3
|
Tumeur fibreuse solitaire maligne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8820/0
|
Élastofibrome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8821/1
|
Fibromatose agressive
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8822/1
|
Fibromatose abdominale
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8823/0
|
Fibrome desmoplasique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8824/0
|
Myofibrome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8824/1
|
Myofibromatose
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8825/0
|
Myofibroblastome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8825/1
|
Tumeur myofibroblastique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8826/0
|
Angiomyofibroblastome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8827/1
|
Tumeur myofibroblastique péribronchique (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8830/0
|
Histiocytome fibreux bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8830/1
|
Histiocytome fibreux atypique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8830/3
|
Histiocytome fibreux malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8831/0
|
Histiocytome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8832/0
|
Dermatofibrome, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8832/3
|
Dermatofibrosarcome, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8833/3
|
Dermatofibrosarcome protubérant pigmenté (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8834/1
|
Fibroblastome à cellules géantes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8835/1
|
Tumeur fibrohistiocytaire plexiforme
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8836/1
|
Histiocytome fibreux angiomatoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8840/0
|
Myxome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8840/3
|
Myxosarcome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8841/1
|
Angiomyxome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8842/0
|
Tumeur fibromyxoïde ossifiante
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8850/0
|
Lipome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8850/1
|
Lipome atypique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8850/3
|
Liposarcome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8851/0
|
Fibrolipome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8851/3
|
Liposarcome bien différencié
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8852/0
|
Fibromyxolipome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8852/3
|
Liposarcome myxoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8853/3
|
Liposarcome à cellules rondes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8854/0
|
Lipome pléomorphe
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8854/3
|
Liposarcome pléomorphe
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8855/3
|
Liposarcome à cellularité mixte
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8856/0
|
Lipome intramusculaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8857/0
|
Lipome à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8857/3
|
Liposarcome fibroblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8858/3
|
Liposarcome dédifférencié
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8860/0
|
Angiomyolipome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8861/0
|
Angiolipome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8862/0
|
Lipome chondroïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8870/0
|
Myélolipome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8880/0
|
Hibernome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8881/0
|
Lipoblastomatose
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8890/0
|
Léiomyome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8890/1
|
Léiomyomatose, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8890/3
|
Léiomyosarcome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8891/0
|
Léiomyome épithélioïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8891/3
|
Léiomyosarcome épithélioïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8892/0
|
Léiomyome cellulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8893/0
|
Léiomyome bizarre
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8894/0
|
Angiomyome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8894/3
|
Angiomyosarcome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8895/0
|
Myome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8895/3
|
Myosarcome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8896/3
|
Leiomyosarcome myxoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8897/1
|
Tumeur des muscles lisses à potentiel malin incertain
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8898/1
|
Leiomyome métastasant
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8900/0
|
Rhabdomyome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8900/3
|
Rhabdomyosarcome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8901/3
|
Rhabdomyosarcome pléomorphe de type adulte
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8902/3
|
Rhabdomyosarcome à cellularité mixte
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8903/0
|
Rhabdomyome fœtal
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8904/0
|
Rhabdomyome adulte
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8905/0
|
Rhabdomyome génital (C51.-, C52.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8910/3
|
Rhabdomyosarcome embryonnaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8912/3
|
Rhabdomyosarcome à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8920/3
|
Rhabdomyosarcome alvéolaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8921/3
|
Rhabdomyosarcome avec différenciation ganglionnaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8930/0
|
Nodule du stroma endométrial (C54.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8930/3
|
Sarcome du stroma endométrial , SAI (C54.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8931/3
|
Sarcome du stroma endométrial de bas grade (C54.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8932/0
|
Adénomyome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8933/3
|
Adénosarcome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8934/3
|
Carcinofibrome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8935/0
|
Tumeur stromale bénigne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8935/1
|
Tumeur stromale, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8935/3
|
Sarcome stromal, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8936/0
|
Tumeur bénigne du stroma gastro-intestinal
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8936/1
|
Tumeur du stroma gastro-intestinal, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8936/3
|
Sarcome du stroma gastro-intestinal
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8940/0
|
Adénome polymorphe
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8940/3
|
Tumeur mixte maligne, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8941/3
|
Carcinome sur adénome pléomorphe (C07.-, C08.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8950/3
|
Mulleroblastome (C54.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8951/3
|
Tumeur mixte mésodermique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8959/0
|
Néphrome kystique bénin (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8959/1
|
Néphroblastome kystique partiellement différencié (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8959/3
|
Néphrome kystique malin (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8960/1
|
Néphrome mésoblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8960/3
|
Néphroblastome, SAI (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8963/3
|
Tumeur rhabdoïde maligne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8964/3
|
Sarcome à cellules claires du rein (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8965/0
|
Adénofibrome néphrogène (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8966/0
|
Tumeur à cellules interstitielles rénomédullaires (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8967/0
|
Tumeur rénale ossifiante (C64.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8970/3
|
Hépatoblastome (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8971/3
|
Pancréatoblastome (C25.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8972/3
|
Blastome pulmonaire (C34.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8973/3
|
Blastome pleuropulmonaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8974/1
|
Sialoblastome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8980/3
|
Carcinosarcome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8981/3
|
Carcinosarcome de type embryonnaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8982/0
|
Myoépithéliome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8982/3
|
Myoépithéliome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8983/0
|
Adénomyoépithéliome (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8990/0
|
Mésenchymome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8990/1
|
Mésenchymome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8990/3
|
Mésenchymome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
8991/3
|
Sarcome embryonnaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9000/0
|
Tumeur de Brenner, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9000/1
|
Tumeur de Brenner à la limite de la malignité (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9000/3
|
Tumeur de Brenner maligne (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9010/0
|
Fibroadénome, SAI (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9011/0
|
Fibroadénome intracanaliculaire, (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9012/0
|
Fibroadénome péricanaliculaire (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9013/0
|
Adénofibrome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9014/0
|
Adénofibrome séreux, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9014/1
|
Adénofibrome séreux à la limite de la malignité
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9014/3
|
Adénocarcinofibrome séreux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9015/0
|
Adénofibrome mucineux, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9015/1
|
Adénofibrome mucineux à la limite de la malignité
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9015/3
|
Adénocarcinofibrome mucineux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9016/0
|
Fibro-adénome géant (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9020/0
|
Tumeur phyllode bénigne (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9020/1
|
Tumeur phyllode à la limite de la malignité (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9020/3
|
Tumeur phyllode maligne (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9030/0
|
Fibroadénome juvénile (C50.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9040/0
|
Synoviome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9040/3
|
Sarcome synovial, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9041/3
|
Sarcome synovial à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9042/3
|
Sarcome synovial à cellules épithélioïdes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9043/3
|
Sarcome synovial biphasique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9044/3
|
Sarcome à cellules claires (sauf du rein)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9050/0
|
Mésothéliome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9050/3
|
Mésothéliome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9051/0
|
Mésothéliome fibreux bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9051/3
|
Mésothéliome fibreux malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9052/0
|
Mésothéliome épithélioïde bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9052/3
|
Mésothéliome épithélioïde malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9053/3
|
Mésothéliome biphasique malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9054/0
|
Tumeur adénomatoïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9055/0
|
Mésothéliome polykystique bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9055/1
|
Mésothéliome kystique, SAI (C48.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9060/3
|
Dysgerminome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9061/3
|
Séminome, SAI (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9062/3
|
Séminome anaplasique (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9063/3
|
Séminome spermatocytaire (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9064/2
|
Cellules germinales intratubulaires malignes (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9064/3
|
Germinome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9065/3
|
Tumeur à cellules germinales, non séminomateuse (C62.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9070/3
|
Carcinome embryonnaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9071/3
|
Tumeur vitelline
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9072/3
|
Polyembryome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9073/1
|
Gonadoblastome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9080/0
|
Tératome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9080/1
|
Tératome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9080/3
|
Tératome malin, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9081/3
|
Tératocarcinome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9082/3
|
Tératome malin indifférencié
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9083/3
|
Tératome malin de type intermédiaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9084/0
|
Kyste dermoïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9084/3
|
Kyste dermoïde avec transformation maligne (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9085/3
|
Tumeur mixte des cellules germinales
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9090/0
|
Goitre ovarien, SAI (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9090/3
|
Goitre ovarien cancérisé (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9091/1
|
Carcinoïde et goitre ovarien (C56.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9100/0
|
Môle hydatiforme, SAI (C58.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9100/1
|
Môle hydatiforme invasive, SAI (C58.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9100/3
|
Choriocarcinome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9101/3
|
Choriocarcinome avec autres éléments à cellules germinales
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9102/3
|
Tératome malin trophoblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9103/0
|
Môle hydatiforme partielle (C58.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9104/1
|
Tumeur trophoblastique du site placentaire (C58.9)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9105/3
|
Tumeur trophoblastique épithélioïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9110/0
|
Mésonéphrome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9110/1
|
Tumeur mésonéphrique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9110/3
|
Mésonéphrome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9120/0
|
Hémangiome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9120/3
|
Hémangiosarcome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9121/0
|
Hémangiome caverneux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9122/0
|
Hémangiome veineux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9123/0
|
Hémangiome racémeux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9124/3
|
Sarcome à cellules de Kupffer (C22.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9125/0
|
Hémangiome épithélioïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9130/0
|
Hémangioendothéliome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9130/1
|
Hémangioendothéliome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9130/3
|
Hémangioendothéliome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9131/0
|
Hémangiome capillaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9132/0
|
Hémangiome intramusculaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9133/1
|
Hémangioendothéliome épithélioïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9133/3
|
Hémangioendothéliome épithélioïde malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9135/1
|
Angioendothéliome papillaire endovasculaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9136/1
|
Hémangioendothéliome à cellules fusiformes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9140/3
|
Sarcome de Kaposi
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9141/0
|
Angiokératome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9142/0
|
Hémangiome verruqueux kératosique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9150/0
|
Hémangiopéricytome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9150/1
|
Hémangiopéricytome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9150/3
|
Hémangiopéricytome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9160/0
|
Angiofibrome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9161/0
|
Hémangiome pelotonné acquis
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9161/1
|
Hémangioblastome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9170/0
|
Lymphangiome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9170/3
|
Lymphangiosarcome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9171/0
|
Lymphangiome capillaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9172/0
|
Lymphangiome caverneux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9173/0
|
Lymphangiome kystique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9174/0
|
Lymphangiomyome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9174/1
|
Lymphangiomyomatose
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9175/0
|
Hémolymphangiome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9180/0
|
Ostéome, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9180/3
|
Ostéosarcome, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9181/3
|
Ostéosarcome chondroblastique (C40.- , C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9182/3
|
Ostéosarcome fibroblastique (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9183/3
|
Ostéosarcome télangiectasique (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9184/3
|
Ostéosarcome sur maladie de Paget de l’os (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9185/3
|
Ostéosarcome à petites cellules (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9186/3
|
Ostéosarcome central (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9187/3
|
Ostéosarcome intra-osseux bien différencié (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9191/0
|
Ostéome ostéoïde, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9192/3
|
Ostéosarcome parostéal (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9193/3
|
Ostéosarcome périosté (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9194/3
|
Ostéosarcome de surface de haut grade (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9195/3
|
Ostéosarcome intracortical (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9200/0
|
Ostéoblastome, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9200/1
|
Ostéoblastome agressif (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9210/0
|
Ostéochondrome (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9210/1
|
Ostéochondromatose, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9220/0
|
Chondrome, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9220/1
|
Chondromatose, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9220/3
|
Chondrosarcome, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9221/0
|
Chondrome juxtacortical (C40.-, C41.- )
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9221/3
|
Chondrosarcome juxtacortical (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9230/0
|
Chondroblastome, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9230/3
|
Chondroblastome malin (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9231/3
|
Chondrosarcome myxoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9240/3
|
Chondrosarcome mésenchymateux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9241/0
|
Fibrome chondromyxoïde (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9242/3
|
Chondrosarcome à cellules claires (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9243/3
|
Chondrosarcome dédifférencié (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9250/1
|
Tumeur à cellules géantes de l’os, SAI (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9250/3
|
Tumeur maligne à cellules géantes de l’os (C40.-, C41.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9251/1
|
Tumeur à cellules géantes des tissus mous, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9251/3
|
Tumeur maligne à cellules géantes des tissus mous
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9252/0
|
Tumeur ténosynoviale à cellules géantes (C49.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9252/3
|
Tumeur ténosynoviale maligne à cellules géantes (C49.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9260/3
|
Sarcome d’Ewing
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9261/3
|
Adamantinome des os longs (C40.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9262/0
|
Fibrome ossifiant
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9270/0
|
Tumeur odontogène bénigne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9270/1
|
Tumeur odontogène, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9270/3
|
Tumeur odontogène maligne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9271/0
|
Fibrodentinome améloblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9272/0
|
Cémentome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9273/0
|
Cémentoblastome bénin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9274/0
|
Fibrome cémentifiant
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9275/0
|
Cémentome géant
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9280/0
|
Odontome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9281/0
|
Odontome composé
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9282/0
|
Odontome complexe
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9290/0
|
Fibro-odontome améloblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9290/3
|
Odontosarcome améloblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9300/0
|
Tumeur odontogène adénomatoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9301/0
|
Kyste odontogène calcifiant
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9302/0
|
Tumeur odontogène à cellules fantômes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9310/0
|
Améloblastome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9310/3
|
Améloblastome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9311/0
|
Odontoaméloblastome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9312/0
|
Tumeur odontogène kératinisée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9320/0
|
Myxome odontogène
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9321/0
|
Fibrome odontogène central, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9322/0
|
Fibrome odontogène périphérique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9330/0
|
Fibrome améloblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9330/3
|
Fibrosarcome améloblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9340/0
|
Tumeur odontogène épithéliale calcifiante
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9341/1
|
Tumeur odontogène à cellules claires
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9342/3
|
Carcinosarcome odontogène
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9350/1
|
Craniopharyngiome (C75.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9351/1
|
Craniopharyngiome adamantinomateux (C75.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9352/1
|
Craniopharyngiome papillaire (C75.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9360/1
|
Pinéalome (C75.3)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9361/1
|
Pinéalocytome (C75.3)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9362/3
|
Pinéaloblastome (C75.3)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9363/0
|
Tumeur mélanotique neuroectodermique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9364/3
|
Tumeur neuroectodermique périphérique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9365/3
|
Tumeur de Askin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9370/3
|
Chordome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9371/3
|
Chordome chondroïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9372/3
|
Chordome dédifférencié
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9373/0
|
Parachordome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9380/3
|
Gliome malin (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9381/3
|
Gliomatose du cerveau (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9382/3
|
Gliome mixte (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9383/1
|
Subependymome (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9384/1
|
Astrocytome sous-épendymaire à cellules géantes (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9390/0
|
Papillome des plexus choroïdes, SAI (C71.5)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9390/1
|
Papillome atypique des plexus choroïdes (C71.5)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9390/3
|
Carcinome des plexus choroïdes (C71.5)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9391/3
|
Épendymome, SAI (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9392/3
|
Épendymome anaplasique (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9393/3
|
Épendymome papillaire (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9394/1
|
Épendymome myxopapillaire (C72.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9400/3
|
Astrocytome, SAI (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9401/3
|
Astrocytome anaplasique (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9410/3
|
Astrocytome protoplasmique (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9411/3
|
Astrocytome gémistocytique (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9412/1
|
Astrocytome desmoplastique infantile (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9413/0
|
Tumeur neuroépithéliale dysembryoplasique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9420/3
|
Astrocytome fibrillaire (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9421/3
|
Astrocytome pilocytique (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9423/3
|
Spongioblastome polaire (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9424/3
|
Xanthoastrocytome pléomorphe (C71.- )
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9430/3
|
Astroblastome (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9440/3
|
Glioblastome, SAI (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9441/3
|
Glioblastome à cellules géantes (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9442/1
|
Gliofibrome (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9442/3
|
Gliosarcome (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9444/1
|
Gliome chordoïde (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9450/3
|
Oligodendrogliome, SAI (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9451/3
|
Oligodendrogliome , anaplasique (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9460/3
|
Oligodendroblastome (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9470/3
|
Médulloblastome, SAI (C71.6)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9471/3
|
Médulloblastome nodulaire desmoplastique (C71.6)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9472/3
|
Médullomyoblastome (C71.6)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9473/3
|
Tumeur neuroectodermique primitive, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9474/3
|
Médulloblastome à grandes cellules (C71.6)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9480/3
|
Sarcome cérébelleux, SAI (C71.6)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9490/0
|
Ganglioneurome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9490/3
|
Ganglioneuroblastome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9491/0
|
Ganglioneuromatose
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9492/0
|
Gangliocytome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9493/0
|
Gangliocytome dysplasique du cervelet (maladie de J. Lhermitte et Duclos) (C71.6)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9500/3
|
Neuroblastome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9501/0
|
Médulloépithéliome bénin (C69.4)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9501/3
|
Médullo-épithéliome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9502/0
|
Médullo-épithéliome tératoïde bénin (C69.4)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9502/3
|
Médullo-épithéliome tératoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9503/3
|
Neuroépithéliome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9504/3
|
Spongioneuroblastome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9505/1
|
Gangliogliome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9505/3
|
Gangliogliome anaplasique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9506/1
|
Neurocytome central
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9507/0
|
Tumeur des corpuscules de Pacini
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9508/3
|
Tumeur rhabdoïde/tératoïde atypique (C71.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9510/0
|
Rétinocytome (C69.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9510/3
|
Rétinoblastome, SAI (C69.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9511/3
|
Rétinoblastome différencié (C69.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9512/3
|
Rétinoblastome indifférencié (C69.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9513/3
|
Rétinoblastome diffus (C69.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9514/1
|
Rétinoblastome à régression spontanée (C69.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9520/3
|
Tumeur neurogénique olfactive
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9521/3
|
Neurocytome olfactif
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9522/3
|
Neuroblastome olfactif (C30.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9523/3
|
Neuroépithéliome olfactif (C30.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9530/0
|
Méningiome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9530/1
|
Méningiomatose, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9530/3
|
Méningiome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9531/0
|
Méningiome méningothélial
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9532/0
|
Méningiome fibreux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9533/0
|
Méningiome psammomateux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9534/0
|
Méningiome angiomateux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9535/0
|
Méningiome hémangioblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9537/0
|
Méningiome transitionnel
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9538/1
|
Méningiome à cellules claires
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9538/3
|
Méningiome papillaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9539/1
|
Méningiome atypique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9539/3
|
Sarcomatose méningée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9540/0
|
Neurofibrome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9540/1
|
Neurofibromatose, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9540/3
|
Tumeur maligne de la gaine des nerfs périphériques
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9541/0
|
Neurofibrome mélanotique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9550/0
|
Neurofibrome plexiforme
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9560/0
|
Neurilemmome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9560/1
|
Neurinomatose
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9560/3
|
Neurilemmome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9561/3
|
Tumeur maligne de la gaine des nerfs périphériques avec différenciation rhabdomyoblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9562/0
|
Neurothécome
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9570/0
|
Névrome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9571/0
|
Périneurome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9571/3
|
Périneurome malin
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9580/0
|
Tumeur à cellules granuleuses, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9580/3
|
Tumeur maligne à cellules granuleuses
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9581/3
|
Sarcome alvéolaire des tissus mous
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9582/0
|
Tumeur à cellules granuleuses de la région sellaire (C75.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9590/3
|
Lymphome malin, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9591/3
|
Lymphome malin non-hodgkinien, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9596/3
|
Lymphome à composante hodgkinienne et non-hodgkinienne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9650/3
|
Lymphome de Hodgkin, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9651/3
|
Lymphome de Hodgkin riche en lymphocytes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9652/3
|
Lymphome de Hodgkin, à cellularité mixte, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9653/3
|
Lymphome de Hodgkin, à déplétion lymphoïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9654/3
|
Lymphome de Hodgkin, à déplétion lymphoïde, type fibrose diffuse
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9655/3
|
Lymphome de Hodgkin, à déplétion lymphoïde, type réticulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9659/3
|
Lymphome de Hodgkin à prédominance lymphocytaire, forme nodulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9661/3
|
Granulome hodgkinien
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9662/3
|
Sarcome hodgkinien
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9663/3
|
Lymphome de Hodgkin, sclérose nodulaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9664/3
|
Lymphome de Hodgkin, sclérose nodulaire, phase cellulaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9665/3
|
Lymphome de Hodgkin, sclérose nodulaire, grade 1
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9667/3
|
Lymphome de Hodgkin, sclérose nodulaire, grade 2
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9670/3
|
Lymphome malin à petits lymphocytes B, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9671/3
|
Lymphome malin lymphoplasmocytoïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9673/3
|
Lymphome à cellules du manteau
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9675/3
|
Lymphome malin diffus mixte à petites et grandes cellules
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9678/3
|
Lymphome malin à épanchement primaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9679/3
|
Lymphome médiastinal à grandes cellules B (C38.3)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9680/3
|
Lymphome malin diffus à grandes cellules B, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9684/3
|
Lymphome malin immunoblastique diffus à grandes cellules B, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9687/3
|
Lymphome de Burkitt, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9689/3
|
Lymphome à cellules B de la zone marginale splénique (C42.2)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9690/3
|
Lymphome folliculaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9691/3
|
Lymphome folliculaire, grade 2
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9695/3
|
Lymphome folliculaire, grade 1
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9698/3
|
Lymphome folliculaire, grade 3
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9699/3
|
Lymphome de la zone marginale à cellules B, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9700/3
|
Mycosis fongoïde (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9701/3
|
Maladie de Sézary
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9702/3
|
Lymphome à cellules T matures, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9705/3
|
Lymphome angioimmunoblastique à cellules T
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9708/3
|
Lymphome à cellules T simulant une panniculite
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9709/3
|
Lymphome cutané à cellules T, SAI (C44.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9714/3
|
Lymphome anaplasique à grandes cellules, à cellules T et cellules nulles
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9716/3
|
Lymphome hépatosplénique à cellule gamma-delta
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9717/3
|
Lymphome intestinal à cellules T
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9718/3
|
Syndrome lymphoprolifératif cutané primitif à cellules T CD30+
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9719/3
|
Lymphome à cellules T/NK, type nasal
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9727/3
|
Lymphome lymphoblastique à cellules précurseurs, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9728/3
|
Lymphome lymphoblastique à cellules précurseurs B
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9729/3
|
Lymphome lymphoblastique à cellules précurseurs T
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9731/3
|
Plasmocytome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9732/3
|
Myélome multiple (C42.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9733/3
|
Leucémie à plasmocytes (C42.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9734/3
|
Plasmocytome extramédullaire (ne survenant pas dans l’os)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9740/1
|
Mastocytome, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9740/3
|
Sarcome à mastocytes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9741/3
|
Mastocytose maligne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9742/3
|
Leucémie à mastocytes (C42.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9750/3
|
Histiocytose maligne
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9751/1
|
Histiocytose à cellules de Langerhans, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9752/1
|
Histiocytose à cellules de Langerhans, unifocale
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9753/1
|
Histiocytose à cellules de Langerhans, multifocale
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9754/3
|
Histiocytose à cellules de Langerhans, disséminée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9755/3
|
Sarcome histiocytaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9756/3
|
Sarcome à cellules de Langerhans
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9757/3
|
Sarcome à cellules dendritiques interdigitées
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9758/3
|
Sarcome folliculaire à cellules dendritiques
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9760/3
|
Maladie immunoproliférative, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9761/3
|
Macroglobulinémie de Waldenström (C42.0)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9762/3
|
Maladie des chaînes lourdes, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9764/3
|
Maladie immunoproliférative de l'intestin grêle (C17.-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9765/1
|
Gammapathie monoclonale de signification indéterminée
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9766/1
|
Lésion immunoproliférative angiocentrique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9767/1
|
Lymphadénopathie immunoblastique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9768/1
|
Maladie lymphoproliférative gamma-T
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9769/1
|
Maladie à dépôts d’immunoglobulines
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9800/3
|
Leucémie, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9801/3
|
Leucémie aiguë, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9805/3
|
Leucémie biphénotypique aiguë
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9820/3
|
Leucémie lymphoïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9823/3
|
Leucémie lymphoïde chronique à cellules B/lymphome à petits lymphocytes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9826/3
|
Leucémie à cellules de Burkitt
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9827/3
|
Leucémie/lymphome à cellules T, type adulte (HTLV-1 positif) incluant toutes les variétés
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9831/1
|
Leucémie lymphoïde à grandes cellules T granuleuses
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9832/3
|
Leucémie prolymphocytaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9833/3
|
Leucémie prolymphocytaire à cellules B
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9834/3
|
Leucémie prolymphocytaire à cellules T
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9835/3
|
Leucémie lymphoblastique à cellules précurseurs, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9836/3
|
Leucémie lymphoblastique à cellules précurseurs B
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9837/3
|
Leucémie lymphoblastique à cellules précurseurs T
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9840/3
|
Leucémie myéloïde aiguë, type M6
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9860/3
|
Leucémie myéloïde, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9861/3
|
Leucémie aiguë myéloïde, SAI (type FAB ou OMS non précisé)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9863/3
|
Leucémie myéloïde chronique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9866/3
|
Leucémie promyélocytaire aiguë, t(15;17)(q22;q11-12)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9867/3
|
Leucémie aiguë myélomonocytaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9870/3
|
Leucémie aiguë à basophiles
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9871/3
|
Leucémie myéloïde aiguë avec éosinophiles médullaires anormaux
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9872/3
|
Leucémie aiguë myéloïde, à différenciation minimale
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9873/3
|
Leucémie aiguë myéloïde sans maturation
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9874/3
|
Leucémie aiguë myéloïde avec maturation
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9875/3
|
Leucémie myéloïde chronique, ABL-BCR positif
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9876/3
|
Leucémie myéloïde chronique atypique, ABL-BCR négatif
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9891/3
|
Leucémie aiguë monocytaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9895/3
|
Leucémie myéloïde aiguë avec dysplasie de plusieurs lignées cellulaires
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9896/3
|
Leucémie myéloïde aiguë, t(8;21)(q22;q22)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9897/3
|
Leucémie myéloïde aiguë, anomalies 11q23
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9910/3
|
Leucémie mégacaryoblastique aiguë
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9920/3
|
Leucémie myéloïde aiguë secondaire à une thérapie, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9930/3
|
Sarcome myéloïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9931/3
|
Panmyélose aiguë avec myélofibrose (C42.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9940/3
|
Leucémie à tricholeucocytes (C42.1)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9945/3
|
Leucémie chroniquemyélomonocytaire, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9946/3
|
Leucémie myélomonocytaire juvénile
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9948/3
|
Leucémie agressive à cellules NK
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9950/3
|
Polycythémie vraie
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9960/3
|
Maladie myéloproliférative chronique, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9961/3
|
Myélosclérose avec métaplasie myéloïde
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9962/3
|
Thrombocythémie essentielle
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9963/3
|
Leucémie chronique à polynucléaires neutrophiles
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9964/3
|
Syndrome hyperéosinophilique
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9970/1
|
Syndrome lymphoprolifératif, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9975/1
|
Maladie myéloproliférative, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9980/3
|
Anémie réfractaire
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9982/3
|
Anémie réfractaire avec sidéroblastes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9983/3
|
Anémie réfractaire avec excès de blastes
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9984/3
|
Anémie réfractaire avec excès de blastes en transformation
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9985/3
|
Anémie réfractaire avec dysplasie de plusieurs lignées cellulaires
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9986/3
|
Syndrome myélodysplasique avec syndrome de délétion du bras court du chromosome 5
(5q-)
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9987/3
|
Syndrome myélodysplasique secondaire à une thérapie, SAI
|
International Classification of Diseases for Oncology, version 3. |
0‑L |
9989/3
|
Syndrome myélodysplasique, SAI
|
International Classification of Diseases for Oncology, version 3. |
This value set has 1032 codes in it. In order to keep the publication size manageable,
only a selection (500 codes) of the whole set of codes is shown.
|
|